This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Matthew David Surman: Innovator in Pharmaceutical Chemistry
Introduction
Matthew David Surman is a notable inventor in the field of pharmaceutical chemistry. He has made significant contributions to the development of substituted pyridoindoles, which are utilized in the treatment of various diseases. His innovative work has the potential to impact the pharmaceutical industry positively.
Latest Patents
Matthew David Surman holds a patent for "1-Azinone-Substituted Pyridoindoles As Mch Antagonists." This patent describes substituted pyridoindoles for incorporation in pharmaceutical compositions. The compounds correspond to a specific formula, wherein various substituents are defined, allowing for a range of applications in medical treatments.
Career Highlights
Throughout his career, Matthew has worked with several prominent companies, including Harmony Biosciences, Inc. and Curia Global, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
Matthew David Surman is a dedicated inventor whose work in pharmaceutical chemistry showcases his commitment to advancing medical treatments. His contributions, particularly in the area of substituted pyridoindoles, highlight the importance of innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile